Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Expert Review of Medical Devices|May 3, 2008
Transferability of economic evaluations of medical technologies: a new technology for orthopedic surgeryLotte Steuten, Laura Vallejo-Torres, Terry Young, et al.Journal of Health Services Research & Policy|January 25, 2007
The credibility of health economic models for health policy decision-making: the case of population screening for abdominal aortic aneurysmHelen Campbell, Andrew Briggs, Martin Buxton, et al.Rand Health Quarterly|January 14, 2017
Project Retrosight: Understanding the Returns from Cardiovascular and Stroke Research: The Policy ReportSteven Wooding, Stephen Hanney, Alexandra Pollitt, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 24, 2011
The demand for sports and exercise: results from an illustrative surveyNana Kwame Anokye, Subhash Pokhrel, Martin Buxton, et al.Health Policy (Amsterdam, Netherlands)|January 27, 2009
Searching for cost effectiveness thresholds in the NHSJohn Appleby, Nancy Devlin, David Parkin, et al.The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 22, 2005
Comparison of general practitioner records and patient self-report questionnaires for estimation of costsHema Mistry, Martin Buxton, Louise Longworth, et al.European Journal of Public Health|November 8, 2012
Physical activity in England: who is meeting the recommended level of participation through sports and exercise?Nana Kwame Anokye, Subhash Pokhrel, Martin Buxton, et al.International Journal of Technology Assessment in Health Care|May 8, 2012
Bayesian meta-analysis on medical devices: application to implantable cardioverter defibrillatorsJi-Hee Youn, Joanne Lord, Karla Hemming, et al.BMJ Open|October 16, 2012
Cost-effectiveness of a European preventive cardiology programme in primary care: a Markov modelling approachHema Mistry, Stephen Morris, Matthew Dyer, et al.BMC Medicine|June 17, 2014
Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomesMatthew Glover, Martin Buxton, Susan Guthrie, et al.Pageof 4